The randomized clinical trial (RCT) is the gold standard for definitive evaluation of new therapies. RCTs designed to show that the therapeutic efficacy of a new therapy is not unacceptably inferior ...
Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma Patients Single-arm phase II trials may not be appropriate for testing cytostatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results